↓ Skip to main content

Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients

Overview of attention for article published in Trials, February 2022
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
61 Mendeley